Page 2 - நிறுவனம் க்கு ப்ரோடீந் வடிவமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Icosavax Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares August 02, 2021 16:01 ET | Source: Icosavax, Inc. Icosavax, Inc. Seattle, Washington, UNITED STATES SEATTLE, Aug. 02, 2021 (GLOBE NEWSWIRE) Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases, today announced the closing of its initial public offering of 13,953,332 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase 1,819,999 additional shares, at an initial public offering price of $15.00 per share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Icosavax, were

New yorkUnited statesSouth koreaRiverside plazaJessica yinglingLaurence wattsWilliam blairBroadridge financial solutionsInstitute for protein designLittle dog communications incExchange commissionWilliam blair companyProspectus departmentIcosavax incUniversity of washingtonEquity syndicate prospectus department